Tim Smith

New data expands upon the growing perception that allergenic food introduction early in a child’s life may lessen the possibility of allergy developments.

New data from a study in China suggests that practicing tai chi may benefit cognitive function in adults dealing with diabetes as well as cognitive impairment issues.

A novel allergen and immunotherapy adherence and persistence checklist was developed to allow for more insight into adherence and to open this information to prescribing clinicians.

The FDA’s move to withdraw hydroxyprogesterone caproate injection (Makena) was a joint decision by both the FDA’s Commissioner and its Chief Scientist.

New research on a patient with recalcitrant eosinophilic annular erythema who had been successfully treated with benralizumab suggests a therapeutic possibility for EAE patients.

New data shows that there are several major reasons for the perceptions of patients with hidradenitis suppurativa viewing their own access to healthcare as problematic.

A new study in China showed that a combination of mask and serum containing both salicylic acid and lipohydroxy acid showed improvement in acne.

New data from a study in Egypt suggests that several key factors contribute to some of the negative impacts of psoriasis on mothers of children with the skin condition.

This new data investigated the impacts of social, cultural, and community engagement by adults 50 and older on health care utilization.

A set of highlights from some of the impactful breakthroughs covered in dermatology this past month, including phase 3 trial data bimekizumab, tapinarof, and other treatments.

New data suggest that older dementia patients who also have dementia are recommended to take apixaban, an oral anticoagulant.

New research showed that vitamin D supplements were ineffective in diminishing severity of psoriasis, although questions still remain about the findings.

Patients with dystrophic epidermolysis bullosa face near-constant pain and discomfort. While there are several measures clinicians have to help them, a curative treatment remains elusive.

In another segment of her interview, Armstrong explained the implications of her team’s findings for the newly-developed TYK2 inhibitor for plaque psoriasis, as well as its safety profile data.

New data discussed by Armstrong in this interview shows promising results for the once-per-day TYK2 inhibitor treatment known as TAK-279 for plaque psoriasis.

During his latest interview, Lal further explored the topic of recessive dystrophic epidermolysis bullosa and his experiences helping patients with the rare condition.

This research letter highlighted the results of an allergy work-up and of vaccinations for COVID-19 in patients with a suspicion of mRNA vaccine hypersensitivity.

A recent analysis showed that a combination treatment made of phosphate, adapalene, and benzoyl peroxide known as IDP-126 was well-tolerated and effective in pediatric participants with acne.

New data on peanut allergy and Pediatric Quality of Life Inventory scores sheds light on the burden of allergy on adolescents.

In his recent interview, Lal described the condition of dystrophic epidermolysis bullosa in detail, going into the different forms it can take as well as his experiences treating the condition.

A research letter highlighted recent findings that iREACH educational intervention training may be helpful in preventing peanut allergies.

New research on Medicare beneficiary data suggests that older adults who face food insecurity concerns may be at greater risk of more rapid declines in cognitive health.

New data on topical lovastatin cream 2% demonstrated similar efficacy results to the combination of lovastatin and cholesterol in treating the skin disorder DSAP.

New data highlighted racial and ethnic differences between patients with Merkel cell carcinoma, indicating that rates for survival were roughly similar but other distinctions remained.

New data from a systematic literature review highlighted the connection with tumor necrosis factor-α inhibitors and acne, indicating the need for further study.

Siperstein highlighted some more major takeaways from her conference presentation, including facts about how to determine which patients are good candidates for microneedling.

In this interview, Siperstein explained some of the biggest takeaways from her conference presentation on advances in microneedling techniques, including radiofrequency specifically.

Speaking about one of his conference presentations, Chovatiya highlights the biggest takeaways regarding JAK inhibitors for alopecia areata, vitiligo, eczema, psoriasis, and more.

In another interview segment, Cohen described several other major takeaways from his conference presentation on psoriasis, comorbidities, and therapies.

In a conference interview, Cohen delved into the major takeaways covered in his presentation on the latest information related to psoriasis and its therapy.